ClinicalTrials.Veeva

Menu

Inhibitory Control: Effects of Modulation

Butler Hospital logo

Butler Hospital

Status

Enrolling

Conditions

Young Adults

Treatments

Device: Transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04247334
1352651-9

Details and patient eligibility

About

Inhibitory control is relevant to many clinical disorders, including substance abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. This proposal is designed to assess brain networks related to response inhibition in healthy young adults, and use neuromodulation to change these networks and behavioral performance on a response inhibition task. Having an understanding of the brain mechanisms involved in response inhibition may enable us to improve pre-existing treatments for disorders with inhibitory control difficulties.

Enrollment

108 estimated patients

Sex

All

Ages

18 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Low (<1sd below the mean on the BRIEF-Inhibit) or high (>1sd above the mean on BRIEF-Inhibit scale)
  2. English fluency to ensure comprehension of study measures and instructions.

Exclusion criteria

  1. Presence of medical conditions contraindicated for tDCS, including history of any known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain tumor, stroke, implanted medical devices, current pregnancy or women of childbearing age not using effective contraception, or any other serious medical conditions or health problems that would interfere with participation (e.g., skin condition)
  2. Inability to undergo MRI
  3. Current substance abuse disorder
  4. Currently prescribed psychiatric medications.
  5. Active mania or psychosis

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

108 participants in 3 patient groups

Cautious Participants
No Intervention group
Description:
Participants who have low scores on a self-report of inhibitory control abilities (BRIEF-Inhibit).
Impulsive Participants- Active Stimulation
Experimental group
Description:
Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to active stimulation.
Treatment:
Device: Transcranial direct current stimulation
Impulsive Participants- Sham Stimulation
Sham Comparator group
Description:
Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to sham stimulation.
Treatment:
Device: Transcranial direct current stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Nicole McLaughlin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems